TR201907274T4 - Kurutulmuş Biyoselüloz Üretimi İçin Yöntem. - Google Patents

Kurutulmuş Biyoselüloz Üretimi İçin Yöntem. Download PDF

Info

Publication number
TR201907274T4
TR201907274T4 TR2019/07274T TR201907274T TR201907274T4 TR 201907274 T4 TR201907274 T4 TR 201907274T4 TR 2019/07274 T TR2019/07274 T TR 2019/07274T TR 201907274 T TR201907274 T TR 201907274T TR 201907274 T4 TR201907274 T4 TR 201907274T4
Authority
TR
Turkey
Prior art keywords
production
biocellulose
dried
dried biocellulose
present
Prior art date
Application number
TR2019/07274T
Other languages
English (en)
Inventor
Young Cha Jae
Min Shin Sang
Ae Moon Mi
Gyu Kim Seung
Su Seo Kwang
Original Assignee
Youcel Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48873627&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR201907274(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Youcel Co Ltd filed Critical Youcel Co Ltd
Publication of TR201907274T4 publication Critical patent/TR201907274T4/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B15/00—Preparation of other cellulose derivatives or modified cellulose, e.g. complexes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241—Containing particulates characterized by their shape and/or structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/731—Cellulose; Quaternized cellulose derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B1/00—Preparatory treatment of cellulose for making derivatives thereof, e.g. pre-treatment, pre-soaking, activation
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
    • C08L1/02—Cellulose; Modified cellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10—General cosmetic use
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/805—Corresponding aspects not provided for by any of codes A61K2800/81 - A61K2800/95

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Mevcut buluş, buluşun bir düzenlemesine göre, nakil ve üretim işlemleri sırasında mikroorganizmaların sebep olduğu kontaminasyonu önleyen, üretim sürecinde mikroorganizmalara karşı ilave bir sistem gerektirmeyen ve oda sıcaklığında uzun bir süre boyunca muhafaza edilerek nakil ve üretim maliyetini azaltabilen, kurutulmuş biyoselüloz üretimine yönelik bir yöntem sağlamaktadır. Ayrıca, mevcut buluşun bir düzenlemesine göre, kurutulmuş biyoselüloz, birkaç saniye veya dakika içerisinde hızla jelleşerek tedavi edici maddeleri taşımak amacıyla kozmetik veya farmasötik bir malzeme olarak kullanılabilir.
TR2019/07274T 2012-01-26 2012-03-30 Kurutulmuş Biyoselüloz Üretimi İçin Yöntem. TR201907274T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020120007705A KR101371379B1 (ko) 2012-01-26 2012-01-26 건조 바이오 셀룰로오스의 제조 방법

Publications (1)

Publication Number Publication Date
TR201907274T4 true TR201907274T4 (tr) 2019-06-21

Family

ID=48873627

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/07274T TR201907274T4 (tr) 2012-01-26 2012-03-30 Kurutulmuş Biyoselüloz Üretimi İçin Yöntem.

Country Status (10)

Country Link
US (2) US10113004B2 (tr)
EP (1) EP2808346B1 (tr)
KR (1) KR101371379B1 (tr)
CN (2) CN108864312A (tr)
DK (1) DK2808346T3 (tr)
ES (1) ES2727335T3 (tr)
HU (1) HUE043342T2 (tr)
PL (1) PL2808346T3 (tr)
TR (1) TR201907274T4 (tr)
WO (1) WO2013111927A1 (tr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102011117136A1 (de) * 2011-10-25 2013-04-25 JeNaCell GmbH Verfahren zur Generierung getrockneter Cellulose und cellulosehaltigen Materials sowie nach diesem Verfahren hergestellte requellbare Celluloseprodukte
TWI586373B (zh) * 2014-02-06 2017-06-11 奈菲兒生醫股份有限公司 含有生物纖維膜碎片之化妝品組成物及其製造方法
KR101631109B1 (ko) 2016-01-20 2016-06-16 이미연 건조 바이오 셀룰로오스의 제조 방법 및 이에 의해 제조된 건조 바이오 셀룰로오스
US11286313B2 (en) * 2016-06-30 2022-03-29 Betulium Oy Parenchymal cellulose composition
KR101708156B1 (ko) * 2016-09-30 2017-02-17 주식회사 유로프 바이오 셀룰로오스 시트, 바이오 셀룰로오스 시트 제품, 및 이들의 제조방법
TWI656216B (zh) * 2017-07-21 2019-04-11 大江生醫股份有限公司 乾式生物纖維材料及其製備方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3696789A (en) * 1988-05-31 1990-01-05 R. Malcolm Brown Microbial cellulose as a building block resource for specialty products and processes therefor
JP2873927B2 (ja) * 1995-04-18 1999-03-24 株式会社バイオポリマー・リサーチ バクテリアセルロースの乾燥方法および乾燥物
JP3155686B2 (ja) * 1995-07-25 2001-04-16 ブンセン株式会社 バイオセルロースの製造方法
JP3735761B2 (ja) * 1997-12-09 2006-01-18 株式会社日本吸収体技術研究所 高吸収性複合体
AU6210300A (en) * 1999-07-15 2001-02-05 Pharmacia Corporation Process for drying reticulated bacterial cellulose without co-agents
US8053216B2 (en) * 2005-05-23 2011-11-08 Cp Kelco U.S., Inc. Bacterial cellulose-containing formulations
US20070128243A1 (en) * 2005-12-02 2007-06-07 Xylos Corporation Implantable microbial cellulose materials for various medical applications
CA2645764C (en) * 2006-03-13 2015-11-03 Xylos Corporation Oxidized microbial cellulose and use thereof
US7709631B2 (en) 2006-03-13 2010-05-04 Xylos Corporation Oxidized microbial cellulose and use thereof
BRPI0601330A (pt) * 2006-03-31 2007-12-04 Wellborn Participacoes Societa composição tópica de biocelulose em forma de gel, spray-aerosol, creme e ou suspensão aquosa para tratamento de lesões epiteliais
KR20100085634A (ko) 2009-01-21 2010-07-29 엘에스엠트론 주식회사 트랙터의 리프트 장치
JP5618173B2 (ja) * 2009-05-01 2014-11-05 株式会社東洋新薬 透明なシート状化粧品
WO2011079380A1 (en) * 2009-12-30 2011-07-07 Axcelon Biopolymers Corporation Transparent bacterial cellulose nanocomposite hydrogels

Also Published As

Publication number Publication date
KR20130086770A (ko) 2013-08-05
ES2727335T3 (es) 2019-10-15
US20150158954A1 (en) 2015-06-11
WO2013111927A1 (ko) 2013-08-01
PL2808346T3 (pl) 2019-08-30
EP2808346A1 (en) 2014-12-03
EP2808346B1 (en) 2019-02-27
CN104379606A (zh) 2015-02-25
HUE043342T2 (hu) 2019-08-28
US20190031787A1 (en) 2019-01-31
KR101371379B1 (ko) 2014-03-07
CN108864312A (zh) 2018-11-23
DK2808346T3 (da) 2019-05-20
EP2808346A4 (en) 2015-10-28
US10113004B2 (en) 2018-10-30

Similar Documents

Publication Publication Date Title
CY1123208T1 (el) Κυκλικα παραγωγα εστερων βορονικου οξεος, μεθοδος για την παρασκευη και θεραπευτικες χρησεις αυτων
MX2015006324A (es) Metodos para la fabricacion de polipeptidos proteoliticamente procesados.
EA201890204A1 (ru) Антибактериальные соединения
MX2021013665A (es) Proteinas de union a calicreina en plasma y usos de las mismas para tratar el angioedema hereditario.
EA033374B1 (ru) Твердые фармацевтические композиции, содержащие энзалутамид, и способ лечения
AR093377A1 (es) Anticuerpos anti-notch y conjugados de anticuerpo-farmaco
BR112017024384A2 (pt) bactérias modificadas para reduzir hiperfenilalaninemia
PH12015500983A1 (en) Heterocyclic substituted 2-amino-quinazoline derivatives for the treatment of viral infections
ECSP14033037A (es) Síntesis de compuestos heterocíclicos
MX2017011997A (es) Carbamatos de piperacina y metodos de preparacion y uso.
BR112015000626A2 (pt) processos para preparação de óxido de titânio e outros produtos variados
TN2014000138A1 (en) Substituted benzylindazoles for use as bub1 kinase inhibitors in the treatment of hyperproliferative diseases.
HK1220980A1 (zh) 用於治疗庞贝氏症的方法和组合物
SG11201601363YA (en) Process for purifying an acid composition comprising 2-formyl-furan-5-carboxylic acid and 2,5-furandicarboxylic acid
CL2016002072A1 (es) 2-amino-3,5,5-trifluoro-3,4,5,6-tetrahidropiridinas como inhibidores de bace1 para el tratamiento de la enfermedad de alzheimer
MX2021001169A (es) Formas sólidas de ácido {[5-(3-clorofenil)-3-hidroxipiridin-2-carb onil]amino}acético, composiciones, y usos de las mismas.
PH12015502535B1 (en) Process for the preparation of erythrocytes loaded with one or more substances of pharmaceutical interest and so obtained erythrocytes
MX2020002544A (es) Sales de glicopirrolato.
MX391040B (es) Formulacion de alta concentracion.
MX2015009276A (es) Donadores de nitroxilo con indice terapeutico mejorado.
WO2014205266A3 (en) Compositions and methods for detecting and treating glioblastoma
IL251770B (en) Granules of an active substance with a double taste masking technique, a method for their production and orally disintegrating tablets containing them
BR112017008097A2 (pt) método para tratar condições oculares
EP3299395A4 (en) OXIDIZED 1,4-OLIGOGLUCURONIC ACID, MANUFACTURING METHOD AND USES THEREOF
EP3352684C0 (fr) Système pour le traitement d'une épistaxis